Protecting Intestinal Barrier Health

Protecting Intestinal Barrier Health

Protectors of Intestinal Integrity

Our mission is to develop and commercialize novel therapeutics that target diseases resulting from a loss of gastrointestinal barrier integrity. This barrier is often damaged during surgeries, leading to extended hospital stays and postoperative complications.

Science

Applying Established Science to Tackle New Challenges

We identify the role of intestinal barrier biology in human disease and develop novel therapeutics that target and improve the integrity of the intestinal barrier.

Our lead program LB1148 is currently being evaluated in a Phase 3 clinical study for accelerating the return of postoperative bowel function and a Phase 2 study for the prevention of post-surgical abdominal adhesions.

Science

Applying Established Science to Tackle New Challenges

We identify the role of intestinal barrier biology in human disease and develop novel therapeutics that target and improve the integrity of the intestinal barrier.

Our lead program LB1148 is currently being evaluated in a Phase 3 clinical study for accelerating the return of postoperative bowel function and a Phase 2 study for the prevention of post-surgical abdominal adhesions.

Research

Studying Impacts on Intestinal Integrity

Leveraging more than three decades of academic research and 15 years of our own internal efforts, we are advancing therapies to help patients with acute and chronic conditions associated with intestinal barrier disruption.

Woman in yellow print dress

Research

Studying Impacts on Intestinal Integrity

Leveraging more than three decades of academic research and 15 years of our own internal efforts, we are advancing therapies to help patients with acute and chronic conditions associated with intestinal barrier disruption.